Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
289 participants
INTERVENTIONAL
2016-02-29
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes
NCT00458133
Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study
NCT02061579
Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity
NCT02043405
Resistance Training in Type 1 Diabetes Mellitus
NCT05315037
The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes
NCT02695810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Strength Training Only
Participants in the strength-training only group will take part in a 9-month exercise intervention at a local exercise facility. They will engage in strength training 3 days per week for approximately 60 minutes each exercise session.
Exercise Intervention
Aerobic Training Only
Participants in the aerobic training only group will take part in a 9-month exercise intervention at a local exercise facility. They will engage in aerobic training over 3 -5 days per week to achieve the targeted dose of 12 kcal/kg per week at a training intensity between 50-80% VO2 max.
Exercise Intervention
Combination (Strength and Aerobic) Training
Participants in the combination (strength and aerobic training) group will take part in a 9-month exercise intervention at a local exercise facility. They will engage aerobic training that will expend 10 kcal/kg/week in combination with strength-training, 3 days per week.
Exercise Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Type 2 Diabetes Mellitus
* BMI between 18.5 -25 kg/m2
* Blood pressure \< 160/100
* Sedentary lifestyle
* Able and willing to enroll and meet requirements of the study
Exclusion Criteria
* Type 1 diabetes or use of insulin pump
* Triglycerides \>500 mg/dL
* Use of weight loss medication
* Bariatric surgery
* Consumes \>14 alcoholic drinks per week
* Pregnancy
* Plans to be away for more than four weeks
* Medical conditions which would prevent long-term participation or which would contraindicate physical activity
30 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Latha Palaniappan, MD, MS
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Latha Palaniappan, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Stanford School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Faroqi L, Bonde S, Goni DT, Wong CW, Wong M, Walai K, Araya S, Azamey S, Schreiner G, Bandy M, Raghuram SS, Mittal A, Mukherji A, Wangdak T, Talamoa R, Vera K, Nacif-Coelho C, Cde LG, Christensen M, Johannsen N, Haddad F, Moharir M, Palaniappan L. STRONG-D: Strength training regimen for normal weight diabetics: Rationale and design. Contemp Clin Trials. 2019 Mar;78:101-106. doi: 10.1016/j.cct.2019.01.005. Epub 2019 Jan 6.
Kobayashi Y, Long J, Dan S, Johannsen NM, Talamoa R, Raghuram S, Chung S, Kent K, Basina M, Lamendola C, Haddad F, Leonard MB, Church TS, Palaniappan L. Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial. Diabetologia. 2023 Oct;66(10):1897-1907. doi: 10.1007/s00125-023-05958-9. Epub 2023 Jul 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.